Ontology highlight
ABSTRACT: Significance
Colorectal cancers express abundant repeat elements that have a viral-like life cycle that can be therapeutically targeted with nucleoside reverse transcriptase inhibitors (NRTI) commonly used for viral diseases. NRTIs induce DNA damage and interferon response that provide a new anticancer therapeutic strategy. This article is highlighted in the In This Issue feature, p. 1397.
SUBMITTER: Rajurkar M
PROVIDER: S-EPMC9167735 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature
Rajurkar Mihir M Parikh Aparna R AR Solovyov Alexander A You Eunae E Kulkarni Anupriya S AS Chu Chong C Xu Katherine H KH Jaicks Christopher C Taylor Martin S MS Wu Connie C Alexander Katherine A KA Good Charly R CR Szabolcs Annamaria A Gerstberger Stefanie S Tran Antuan V AV Xu Nova N Ebright Richard Y RY Van Seventer Emily E EE Vo Kevin D KD Tai Eric C EC Lu Chenyue C Joseph-Chazan Jasmin J Raabe Michael J MJ Nieman Linda T LT Desai Niyati N Arora Kshitij S KS Ligorio Matteo M Thapar Vishal V Cohen Limor L Garden Padric M PM Senussi Yasmeen Y Zheng Hui H Allen Jill N JN Blaszkowsky Lawrence S LS Clark Jeffrey W JW Goyal Lipika L Wo Jennifer Y JY Ryan David P DP Corcoran Ryan B RB Deshpande Vikram V Rivera Miguel N MN Aryee Martin J MJ Hong Theodore S TS Berger Shelley L SL Walt David R DR Burns Kathleen H KH Park Peter J PJ Greenbaum Benjamin D BD Ting David T DT
Cancer discovery 20220601 6
Altered RNA expression of repetitive sequences and retrotransposition are frequently seen in colorectal cancer, implicating a functional importance of repeat activity in cancer progression. We show the nucleoside reverse transcriptase inhibitor 3TC targets activities of these repeat elements in colorectal cancer preclinical models with a preferential effect in p53-mutant cell lines linked with direct binding of p53 to repeat elements. We translate these findings to a human phase II trial of sing ...[more]